AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20580422 — Biomarker: Dipeptidyl peptidase 4
Type: Pharmacodynamic Biomarker (PDY)
Genes: DPP4; ADCP2; CD26
Study 18211120 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 26330303 — Biomarker: SHBG mRNA
Type: Predictive Biomarker (PRD)
Genes: SHBG
Study 17561977 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 23810691 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20946227 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 20946227 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study 20946227 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 20946227 — Biomarker: IL6
Type: Predictive Biomarker (PRD)
Genes: IL-6; BSF2; HGF; HSF
Study 20946227 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 17645482 — Biomarker: Cytochrome P450 2C19
Type: Safety Biomarker (SAF)
Genes: CYP2C19
Study 9812649 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 17563161 — Biomarker: Adrenomedullin
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: ADM; AM
Study 2590918 — Biomarker: CPB1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CPB1; CPB; PCPB
Study 25062713 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 25062713 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 25062713 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 21144516 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study 21144516 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 15486358 — Biomarker: COMT mRNA
Type: Predictive Biomarker (PRD)
Genes: COMT
Study 23790592 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 22653043 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 23579816 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 21336108 — Biomarker: Cystatin C
Type: Safety Biomarker (SAF)
Genes: CST3
Study 27320058 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study 27320058 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 23598289 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17405870 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 17405870 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 17405870 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 8466733 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11878685 — Biomarker: Cardiac troponin I
Type: Safety Biomarker (SAF)
Genes: TNNI3; TNNC1
Study 363480 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18835660 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 18835660 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 11581201 — Biomarker: GCA mRNA
Type: Predictive Biomarker (PRD)
Genes: GCA; GCL
Study 24093862 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 18464882 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 11368289 — Biomarker: ASRGL1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ASRGL1; ALP; CRASH
Study 11368289 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 28900123 — Biomarker: IPP mRNA
Type: Predictive Biomarker (PRD)
Genes: IPP; KLHL27
Study 16675577 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 11223435 — Biomarker: Intercellular adhesion molecule 1
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: ICAM1
Study 11223435 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 8941054 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 8941054 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 16136167 — Biomarker: SLC6A3
Type: Safety Biomarker (SAF)
Genes: DAT
Study 29266398 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 29266398 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 18567824 — Biomarker: PYY mRNA
Type: Predictive Biomarker (PRD)
Genes: PYY
Study 27825977 — Biomarker: Cervical intraepithelial neoplasia
Type: Surrogate Endpoint (SUR)
Study 7435247 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27681944 — Biomarker: KRAS mRNA
Type: Predictive Biomarker (PRD)
Genes: KRAS; KRAS2; RASK2
Study 27681944 — Biomarker: Epiregulin
Type: Safety Biomarker (SAF)
Genes: EREG
Study 24933340 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23543346 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 23543346 — Biomarker: IL-6 and IL-10
Type: Safety Biomarker (SAF)
Study 19508464 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 19508464 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 19508464 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 985067 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 28715503 — Biomarker: CD63 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD63; MLA1; TSPAN30
Study 26168823 — Biomarker: Cardiac troponin I
Type: Safety Biomarker (SAF)
Genes: TNNI3; TNNC1
Study 23883691 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 12552190 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 29851819 — Biomarker: DST mRNA
Type: Predictive Biomarker (PRD)
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 25261340 — Biomarker: MCAT mRNA
Type: Predictive Biomarker (PRD)
Genes: MCAT; MT
Study 25261340 — Biomarker: Heat pain threshold
Type: Pharmacodynamic Biomarker (PDY)
Study 7373 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31568009 — Biomarker: MBTPS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: MBTPS1; KIAA0091; S1P; SKI1
Study 28338229 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18637615 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17060763 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 17060763 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 17060763 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 7523776 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 7523776 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7523776 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 20929988 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18812476 — Biomarker: Dipeptidyl peptidase 4
Type: Pharmacodynamic Biomarker (PDY)
Genes: DPP4; ADCP2; CD26
Study 14760437 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9186882 — Biomarker: PRKD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PRKD1; PKD; PKD1; PRKCM
Study 9186882 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8255512 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 8255512 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3545685 — Biomarker: SHBG mRNA
Type: Predictive Biomarker (PRD)
Genes: SHBG
Study 27745551 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27745551 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 24652467 — Biomarker: Leukocyte surface antigen Leu-16
Type: Predictive Biomarker (PRD)
Genes: MS4A1; CD20
Study 2137218 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30637626 — Biomarker: TRPV4 mRNA
Type: Predictive Biomarker (PRD)
Genes: TRPV4; VRL2; VROAC
Study 22971278 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 27238752 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 21076630 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 21076630 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21076630 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 21076630 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 10333775 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 1758526 — Biomarker: EPX mRNA
Type: Predictive Biomarker (PRD)
Genes: EPX; EPER; EPO; EPP
Study 20448126 — Biomarker: CD34 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD34
Study 20448126 — Biomarker: CXCR4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CXCR4
Study 20448126 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 20448126 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 20448126 — Biomarker: Intercellular adhesion molecule 1
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: ICAM1
Study 20448126 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 15593387 — Biomarker: SLC6A3
Type: Safety Biomarker (SAF)
Genes: DAT
Study 12805079 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10536648 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 6120945 — Biomarker: Angiotensinogenase renin
Type: Pharmacodynamic Biomarker (PDY)
Genes: REN
Study 6120945 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30694715 — Biomarker: TGFB2 mRNA
Type: Predictive Biomarker (PRD)
Genes: TGFB2
Study 30694715 — Biomarker: CHRNA3 mRNA
Type: Predictive Biomarker (PRD)
Genes: CHRNA3; NACHRA3
Study 30694715 — Biomarker: PDE11A mRNA
Type: Predictive Biomarker (PRD)
Genes: PDE11A
Study 30694715 — Biomarker: NEGR1 mRNA
Type: Predictive Biomarker (PRD)
Genes: NEGR1; IGLON4; UNQ2433/PRO4993
Study 30694715 — Biomarker: CADM2 mRNA
Type: Predictive Biomarker (PRD)
Genes: CADM2; IGSF4D; NECL3
Study 30694715 — Biomarker: PCDH7 mRNA
Type: Predictive Biomarker (PRD)
Genes: PCDH7; BHPCDH
Study 30694715 — Biomarker: RETREG1 mRNA
Type: Predictive Biomarker (PRD)
Genes: RETREG1; FAM134B; JK1
Study 30694715 — Biomarker: DACT2 mRNA
Type: Predictive Biomarker (PRD)
Genes: DACT2; C6orf116; PP13671
Study 30694715 — Biomarker: NRG1 mRNA
Type: Predictive Biomarker (PRD)
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study 25965846 — Biomarker: FER mRNA
Type: Predictive Biomarker (PRD)
Genes: FER; TYK3
Study 23812622 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8562146 — Biomarker: Thymidylate synthase 
Type: Predictive Biomarker (PRD)
Genes: TYMS; TS; OK/SW-cl.29
Study 2698941 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25630040 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 21525253 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 16699970 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27965306 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 27965306 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 25387312 — Biomarker: RALA mRNA
Type: Predictive Biomarker (PRD)
Genes: RALA; RAL
Study 25387312 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 23276806 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 21621992 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 8656503 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 8656503 — Biomarker: Beta-2-microglobulin
Type: Safety Biomarker (SAF)
Genes: B2M; CDABP0092; HDCMA22P
Study 31834128 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25779222 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study 15784639 — Biomarker: Complement factor D
Type: Safety Biomarker (SAF)
Genes: CFD; DF; PFD
Study 7607973 — Biomarker: Eosinophil cationic protein
Type: Safety Biomarker (SAF)
Genes: RNASE3; ECP; RNS3
Study 24217684 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18630561 — Biomarker: LARS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: LARS1; KIAA1352; LARS
Study 20553629 — Biomarker: Serum LDL cholesterol
Type: Surrogate Endpoint (SUR)
Study 16118787 — Biomarker: ADORA2A
Type: Safety Biomarker (SAF)
Genes: RDC8
Study 17105777 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study 17105777 — Biomarker: FLT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: FLT1; FLT; FRT; VEGFR1
Study 17105777 — Biomarker: Vascular endothelial growth factor receptor 2
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: KDR; FLK1; VEGFR2
Study 17105777 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 17105777 — Biomarker: Angiopoietin-1
Type: Monitoring Biomarker (MOI)
Genes: ANGPT1; KIAA0003
Study 26957279 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 26957279 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 26957279 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24145083 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 24145083 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 18313521 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 16550749 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 14967827 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29891745 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 29891745 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 18191684 — Biomarker: SAT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SAT1; SAT
Study 6379305 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 26892128 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 26892128 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 26892128 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 19709693 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 19709693 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 19709693 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 17381714 — Biomarker: Mitochondrial DNA
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 12110412 — Biomarker: SHBG mRNA
Type: Predictive Biomarker (PRD)
Genes: SHBG
Study 12110412 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 11011336 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29783863 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28689624 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25600421 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21975206 — Biomarker: TNFRSF10A mRNA
Type: Predictive Biomarker (PRD)
Genes: TNFRSF10A; APO2; DR4; TRAILR1
Study 17137405 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 9310603 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30041929 — Biomarker: ALK
Type: Predictive Biomarker (PRD)
Genes: CD246; ALK1
Study 23522096 — Biomarker: Thyroid stimulating hormone
Type: Safety Biomarker (SAF)
Study 21364273 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 11684941 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 31115304 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study 26530491 — Biomarker: AR mRNA
Type: Predictive Biomarker (PRD)
Genes: AR; DHTR; NR3C4
Study 18840576 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 18840576 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24526178 — Biomarker: Cellular tumor antigen p53
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: TP53; P53
Study 8781634 — Biomarker: HP mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: HP
Study 29788075 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 22441644 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 9879606 — Biomarker: AMT mRNA
Type: Predictive Biomarker (PRD)
Genes: AMT; GCST
Study 2481532 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 810198 — Biomarker: TRH mRNA
Type: Predictive Biomarker (PRD)
Genes: TRH
Study 28549430 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 10754455 — Biomarker: LTB mRNA
Type: Predictive Biomarker (PRD)
Genes: LTB; TNFC; TNFSF3
Study 8862229 — Biomarker: MFSD11 mRNA
Type: Predictive Biomarker (PRD)
Genes: MFSD11; ET
Study 22924248 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10860190 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 10860190 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8470417 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20117244 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 24552979 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 17255295 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 8276554 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 27592487 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 9523374 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 21804130 — Biomarker: Cholesteryl ester transfer protein
Type: Pharmacodynamic Biomarker (PDY)
Genes: CETP
Study 21945448 — Biomarker: XG mRNA
Type: Predictive Biomarker (PRD)
Genes: XG; PBDX
Study 21945448 — Biomarker: LPP mRNA
Type: Predictive Biomarker (PRD)
Genes: LPP
Study 21945448 — Biomarker: PPA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PPA1; IOPPP; PP
Study 21945448 — Biomarker: TRIP10 mRNA
Type: Predictive Biomarker (PRD)
Genes: TRIP10; CIP4; STOT; STP
Study 8724108 — Biomarker: LPL mRNA
Type: Predictive Biomarker (PRD)
Genes: LPL; LIPD
Study 8724108 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 8724108 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 2416412 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 2416412 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9164914 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 27578313 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23865696 — Biomarker: Serum luteinizing hormone
Type: Surrogate Endpoint (SUR)
Study 16652426 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 12796754 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8943183 — Biomarker: Lactate dehydrogenase
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 30842540 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27176461 — Biomarker: Microtubule-associated protein tau
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: MAPT; MAPTL; MTBT1; TAU
Study 27176461 — Biomarker: Apolipoprotein E
Type: Predictive Biomarker (PRD)
Genes: APOE
Study 26545456 — Biomarker: BDNF mRNA
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: BDNF
Study 26545456 — Biomarker: BDNF
Type: Safety Biomarker (SAF)
Study 26545456 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 16380390 — Biomarker: Thyroid stimulating hormone
Type: Safety Biomarker (SAF)
Study 8970411 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16847538 — Biomarker: POMC
Type: Predictive Biomarker (PRD)
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 27185725 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 27185725 — Biomarker: MBP mRNA
Type: Predictive Biomarker (PRD)
Genes: MBP
Study 24376009 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 14672887 — Biomarker: ACR mRNA
Type: Predictive Biomarker (PRD)
Genes: ACR; ACRS
Study 11137832 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 9439404 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study 8339624 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 23000125 — Biomarker: Hemagglutination inhibition antibody
Type: Surrogate Endpoint (SUR)
Study 19393843 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17613395 — Biomarker: Interleukin 17
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: IL17A; CTLA8; IL17
Study 15135473 — Biomarker: SLN mRNA
Type: Predictive Biomarker (PRD)
Genes: SLN